IDiyas

For the Inventor, By the Inventor

Sibenik, Croatia

Dijana Pesic

USPTO Granted Patents = 10

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Sibanik, HR (2005)
  • Sibenik, HR (2007 - 2009)
  • Zagreb, HR (2021 - 2022)

Company Filing History:

goldMedal2 out of 8 
 
Glaxosmithkline Istrazivacki Centar Zagreb D.o.o.
 patents
silverMedal2 out of 4 
 
Pliva-istrazivacki Institut D.o.o.
 patents
bronzeMedal1 out of 1 
 
Fidelta D.o.o.
 patent
4. 1 out of 2 
 
Glaxosmithkline Istrazivacki Center Zagreb D.o.o
 patents
5. 1 out of 1 
 
Glaxosmithkline Istraziva{hacek Over (c)}ki Centar Zagreb D.o.o.
 patent
6. 1 out of 1 
 
Selvita D.o.o.
 patent
7. 1 out of 1 
 
Glaxosmith Kline Istrazivocki Centar Zagreb, D.o.o.
 patent
8. 1 out of 356 
 
Glaxosmithkline LLC
 patents

Years Active: 2005-2022

Loading Chart...
10 patents (USPTO):Explore Patents
1. 11512096 - Seco macrolide compounds (2022-11-29),
2. 10919910 - Seco macrolide compounds (2021-02-16),
3. 7550498 - 1,2-Diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof (2009-06-23),
4. 7435834 - 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof (2008-10-14),
5. 7312203 - 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof (2007-12-25),
6. 7262309 - 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof (2007-08-28),
7. 7262302 - 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof (2007-08-28),
8. 7232815 - 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof (2007-06-19),
9. 7166583 - 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof (2007-01-23),
10. 6897211 - Thienodibenzoazulene compounds as tumor necrosis factor inhibitors (2005-05-24),

As a specialist in inventions, inventors, and patents, I'll gladly assist you with the article about inventor Dijana Pesic.

Title: Unveiling the Innovations of Dijana Pesic: A Visionary in the Field of Macrolide Compounds

Introduction:

Dijana Pesic, a prolific inventor hailing from Sibenik, Croatia, has made significant strides in the realm of seco macrolide compounds through his ingenious patents and contributions to the field.

Latest Patents:

With an impressive inventory of 10 patents to his name, Dijana Pesic's groundbreaking work predominantly revolves around seco macrolide compounds. His latest patents showcase the utilization of these compounds as intermediates for the synthesis of macrolide-based macrocycles, paving the way for novel pharmaceutical compositions and therapeutic agents.

Career Highlights:

Having lent his expertise to esteemed companies such as GlaxoSmithKline Istrazivacki Centar Zagreb and Pliva-Istrazivacki Institut, Dijana Pesic has honed his craft in the research and development sector, spearheading innovative solutions in drug discovery and formulation.

Collaborations:

Throughout his career, Dijana Pesic has collaborated closely with notable colleagues like Milan Mesic and Mladen Mercep, fostering an environment of shared knowledge and expertise in pushing the boundaries of macrolide-based research.

Conclusion:

In conclusion, Dijana Pesic stands as a trailblazer in the field of seco macrolide compounds, with his relentless pursuit of innovation and dedication to advancing pharmaceutical science setting him apart as a visionary inventor. His contributions continue to shape the landscape of drug development, promising a future rich in transformative therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…